The invention discloses a MCSP epitope recognized by CD4+ T lymphocytes. MCSP-specific T-cell clones from the peripheral blood of a healthy human donor could…
A new receptor-dead BMP-2 mutein L51P has been created that has no detectable BMP activity. Surprisingly, the BMP-2 L51P mutein exhibits an unaltered binding…
The invention describes a method to identify T-cells (CTL, CD4+ T-helper), which are specifically directed to or have a highly specific cross-reactivity with…
The invention relates to a method for monitoring the expression level of a gene in a host by modulating the activity of a regulatory biomolecule. The…
The recombinant TLR-MD-2 fusion protein or a fusion protein homopolymer / heteropolymer complex can be used for the prophylactic and/or therapeutic treatment…
The novel conjugate molecules are provided for the manufacture of a medicament for gene therapy, apoptosis, or for the treatment of diseases such as cancer,…